Janux Therapeutics, Inc.
JANX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001817713
No open-market purchases or sales by Janux Therapeutics, Inc. insiders were filed in the last 90 days; 197 institutions reported holding it in 13F filings for Q2 2026, worth $933.4M in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Janux Therapeutics, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 44
- −2 vs. Q1 2022
- Shares held
- 28.9M
- +525.5K (+1.9%) vs. Q1 2022
- Total value
- $353.0M
- −$54.1M (−13.3%) vs. Q1 2022
- New holders
- 3
- 15 more added
- Sold out
- 5
- 15 more reduced
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting JANX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 197 | $933.4M |
| Q1 2026 | 190 | $827.8M |
| Q4 2025 | 176 | $860.0M |
| Q3 2025 | 174 | $1.59B |
| Q2 2025 | 174 | $1.51B |
| Q1 2025 | 181 | $1.81B |
| Q4 2024 | 216 | $3.43B |
| Q3 2024 | 160 | $2.07B |
| Q2 2024 | 155 | $1.87B |
| Q1 2024 | 121 | $1.59B |
| Q4 2023 | 64 | $359.5M |
| Q3 2023 | 57 | $354.0M |
| Q2 2023 | 54 | $362.1M |
| Q1 2023 | 48 | $369.5M |
| Q4 2022 | 50 | $381.3M |
| Q3 2022 | 49 | $400.3M |
| Q2 2022 | 44 | $353.0M |
| Q1 2022 | 47 | $407.1M |
| Q4 2021 | 46 | $541.6M |
| Q3 2021 | 45 | $571.2M |
| Q2 2021 | 30 | $614.5M |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Janux Therapeutics, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Credit Suisse AG | 17 | $0 | 0.00% | +17 | New |
| Royal Bank of Canada | 97 | $1.00K | 0.00% | −995−91.1% | Reduced |
| Daiwa Securities Group Inc. | 121 | $1.00K | 0.00% | 00.0% | Unchanged |
| Crewe Advisors LLC | 115 | $1.00K | 0.00% | +115 | New |
| Barclays PLC | 860 | $11.0K | 0.00% | −2,088−70.8% | Reduced |
| Ameritas Investment Partners, Inc. | 1,014 | $12.0K | 0.00% | 00.0% | Unchanged |
| Metropolitan Life Insurance Co | 1,382 | $16.9K | 0.00% | 00.0% | Unchanged |
| Legal & General Group Plc | 1,440 | $18.0K | 0.00% | −260−15.3% | Reduced |
| Tower Research Capital LLC (TRC) | 1,964 | $24.0K | 0.00% | +722+58.1% | Added |
| Citigroup Inc | 2,151 | $26.0K | 0.00% | +301+16.3% | Added |
| Amalgamated Bank | 2,182 | $27.0K | 0.00% | +254+13.2% | Added |
| California State Teachers Retirement System | 7,338 | $90.0K | 0.00% | −241−3.2% | Reduced |
| New York State Common Retirement Fund | 8,013 | $98.0K | 0.00% | −7,508−48.4% | Reduced |
| American International Group, Inc. | 8,032 | $98.0K | 0.00% | −781−8.9% | Reduced |
| Deutsche Bank AG | 9,242 | $113.0K | 0.00% | −1,356−12.8% | Reduced |
| MetLife Investment Management | 10,614 | $129.6K | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 15,864 | $194.0K | 0.00% | −2,070−11.5% | Reduced |
| Rhumbline Advisers | 23,902 | $292.0K | 0.00% | +7,686+47.4% | Added |
| Bank of America Corp | 25,518 | $312.0K | 0.00% | −15,641−38.0% | Reduced |
| Morgan Stanley | 27,733 | $337.0K | 0.00% | −100.0% | Reduced |
| Wells Fargo & Company | 29,640 | $362.0K | 0.00% | +24,898+525.1% | Added |
| Parkwood LLC | 33,750 | $412.0K | 0.08% | +5,492+19.4% | Added |
| Bank of New York Mellon Corp | 42,386 | $517.0K | 0.00% | −3,615−7.9% | Reduced |
| Charles Schwab Investment Management Inc | 42,510 | $520.0K | 0.00% | −1,890−4.3% | Reduced |
| DekaBank Deutsche Girozentrale | 49,500 | $566.0K | 0.00% | +49,500 | New |
| Nuveen Asset Management, LLC | 74,873 | $915.0K | 0.00% | +49,213+191.8% | Added |
| JPMorgan Chase & Co | 103,478 | $1.26M | 0.00% | +85,552+477.3% | Added |
| Northern Trust Corp | 133,157 | $1.63M | 0.00% | −7,090−5.1% | Reduced |
| Cerity Partners LLC | 150,933 | $1.84M | 0.02% | 00.0% | Unchanged |
| State Street Corp | 264,022 | $3.22M | 0.00% | +22,024+9.1% | Added |
| Geode Capital Management, LLC | 283,620 | $3.46M | 0.00% | +8,389+3.0% | Added |
| Woodline Partners LP | 286,383 | $3.50M | 0.06% | +8,060+2.9% | Added |
| Samsara BioCapital, LLC | 360,414 | $4.40M | 1.18% | −51,457−12.5% | Reduced |
| Adage Capital Partners GP, L.L.C. | 400,000 | $4.88M | 0.01% | 00.0% | Unchanged |
| 5AM Venture Management, LLC | 446,266 | $5.45M | 1.35% | 00.0% | Unchanged |
| Vanguard Group Inc | 649,640 | $7.93M | 0.00% | +83,661+14.8% | Added |
| BlackRock Inc. | 1,208,354 | $14.8M | 0.00% | +46,633+4.0% | Added |
| EcoR1 Capital, LLC | 1,421,319 | $17.4M | 0.60% | 00.0% | Unchanged |
| BVF Inc | 1,470,334 | $18.0M | 0.87% | +327,994+28.7% | Added |
| Citadel Advisors LLC | 1,853,432 | $22.6M | 0.03% | 00.0% | Unchanged |
| Janus Henderson Group PLC | 2,127,797 | $26.0M | 0.02% | −211,349−9.0% | Reduced |
| OrbiMed Advisors LLC | 2,836,386 | $34.6M | 0.67% | 00.0% | Unchanged |
| FMR LLC | 5,825,704 | $71.1M | 0.01% | +148,778+2.6% | Added |
| Ra Capital Management, L.P. | 8,670,644 | $105.9M | 2.82% | 00.0% | Unchanged |
| State of Wisconsin Investment Board | 0 | $0 | 0.00% | −17,700−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −11,480−100.0% | Sold out |
| Allspring Global Investments Holdings, LLC | 0 | $0 | 0.00% | −4,742−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −3,500−100.0% | Sold out |
| Kayne Anderson Rudnick Investment Management LLC | 0 | $0 | 0.00% | −42−100.0% | Sold out |
| Amalgamated Financial Corp. | – | – | – | – | Not filed |